DTIL insider files Form 144 for 34,799 shares

DTIL reported a Form 144 filing in which Michael Amoroso indicated a sale of 34,799 common shares on 01/22/2026 for $145,202.30.

Rhea-AI Filing Summary

DTIL reported a Form 144 filing in which Michael Amoroso indicated a sale of 34,799 common shares on 01/22/2026 for $145,202.30. The filing also shows 20,559 common shares vested as restricted stock on 02/17/2026 as compensation.

Insights

Corporate Governance Analyst

Routine insider sale and related restricted stock vesting were disclosed.

The filing lists a proposed or reported sale of 34,799 common shares with proceeds of $145,202.30, and separately records the vesting of 20,559 common shares as restricted stock on 02/17/2026.

These items are administrative disclosures of insider activity and compensation; timing and further trading details are governed by applicable rules and the broker-dealer handling the sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the DTIL Form 144 disclose?

The Form 144 disclosed a reported sale of 34,799 common shares and the vesting of 20,559 common shares as restricted stock. The sale is shown with a transaction date of 01/22/2026 and the vesting date is 02/17/2026.

Who filed the Form 144 for DTIL?

The filing lists Michael Amoroso as the reporting person and shows Fidelity Brokerage Services LLC as the broker. The document includes addresses for both the reporting person and the brokerage firm as presented in the excerpt.

How much proceeds were reported for the DTIL sale?

The Form 144 shows proceeds of $145,202.30 associated with the reported sale of 34,799 common shares. That dollar amount appears alongside the sale entry dated 01/22/2026 in the excerpt.

What shares vested as compensation in the DTIL filing?

The excerpt shows 20,559 common shares vested as restricted stock on 02/17/2026 under a compensation entry. The record labels the vesting as restricted stock vesting tied to the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001830874
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECISION BIOSCIENCES INC
SEC File Number	001-38841
Address of Issuer	302 EAST PETTIGREW STREET SUITE A-100 DURHAM NORTH CAROLINA 27701
Phone	919-314-5512
Name of Person for Whose Account the Securities are To Be Sold	Amoroso Michael
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20559	79018.52	13256751	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			20559	02/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Amoroso 302 East Pettigrew St., Suite A-100 Durham NC 27701	Common	01/22/2026	34799	145202.30

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Eric Janiak, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Amoroso
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)